PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,585,198 | -10.6% | 1,310,048 | +23.5% | 0.21% | -0.5% |
| Q2 2023 | $15,187,864 | +284.1% | 1,060,605 | +91.5% | 0.21% | +215.2% |
| Q1 2023 | $3,954,339 | -36.1% | 553,829 | +0.4% | 0.07% | -42.6% |
| Q4 2022 | $6,191,499 | +1.2% | 551,827 | -0.1% | 0.12% | +7.5% |
| Q3 2022 | $6,121,000 | +30.4% | 552,442 | -0.7% | 0.11% | +27.4% |
| Q2 2022 | $4,694,000 | -38.0% | 556,105 | -0.0% | 0.08% | +20.0% |
| Q1 2022 | $7,571,000 | -29.5% | 556,293 | +1.9% | 0.07% | +14.8% |
| Q4 2021 | $10,741,000 | -39.2% | 546,055 | -0.8% | 0.06% | -33.7% |
| Q3 2021 | $17,663,000 | -4.5% | 550,240 | +0.7% | 0.09% | +1.1% |
| Q2 2021 | $18,500,000 | -39.8% | 546,522 | -33.2% | 0.09% | -45.2% |
| Q1 2021 | $30,739,000 | – | 818,385 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 4,901,358 | $41,368,000 | 8.59% |
| Frazier Life Sciences Management, L.P. | 5,827,415 | $49,183,000 | 4.64% |
| Abingworth LLP | 1,435,106 | $12,112,000 | 3.88% |
| Penn Mutual Asset Management | 86,940 | $734,000 | 0.99% |
| 683 Capital Management, LLC | 1,440,000 | $12,153,000 | 0.86% |
| Western Standard LLC | 109,055 | $920,000 | 0.70% |
| MPM BioImpact LLC | 193,326 | $1,632,000 | 0.45% |
| Newtyn Management, LLC | 255,767 | $2,159,000 | 0.41% |
| StepStone Group LP | 422,085 | $3,562,000 | 0.38% |
| Avidity Partners Management LP | 1,919,800 | $16,203,000 | 0.37% |